Efficacy and Safety of Recombinant Human Activated Protein C for Severe Sepsis
Treatment with drotrecogin alfa activated significantly reduces mortality in patients with severe sepsis and may be associated with an increased risk of bleeding.
Publications
View AllAffiliated Researchers
Institution Info
- Type
- healthcare
- Country
- CA
- Publications
- 1
- Citations
- 6,116
External Links
Identifiers
- ROR
- https://ror.org/00wg2b048